⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0002024711

Efron Paul

Reports to the SEC for 1 company · BRIDGEWATER, NJ

Transactions

8

Companies

1

Filings

4

CIK

0002024711

Forms 4 and 5

Insider transactions

8 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-15	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+4,406 sh	—	—	8,390
2026-06-02	Keenova Therapeutics plcM Exercise/Conversion	Director	MExercise/Conversion	+3,580 sh	—	—	12,045
2026-06-02	Keenova Therapeutics plcF Tax Payment	Director	FTax Payment	−825 sh	—	—	11,220
2026-06-02	Keenova Therapeutics plcRestricted Stock UnitsD Disposition to Issuer	Director	DDisposition to Issuer	−2,930 sh	—	—	7,564
2026-06-02	Keenova Therapeutics plcRestricted Stock UnitsM Exercise/Conversion	Director	MExercise/Conversion	−3,580 sh	—	—	3,984
2026-02-23	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+3,984 sh	—	—	10,494
2025-08-18	Keenova Therapeutics plcA Award	Director	AAward	+7,692 sh	$92.30	+$710K	8,465
2025-08-14	Keenova Therapeutics plcRestricted Stock UnitsA Award	Director	AAward	+5,417 sh	—	—	5,417

Recent filings

4

Accepted (ET)
Jul 174
Efron Paul0001104659-26-084777
SEC(opens sec.gov)
Jun 44
Efron Paul0001104659-26-070525
SEC(opens sec.gov)
Feb 254
Efron Paul0001104659-26-019924
SEC(opens sec.gov)
Aug 184
Efron Paul0001104659-25-079944
SEC(opens sec.gov)

Companies

1

Keenova Therapeutics plcDirector

Address

440 ROUTE 22 EAST, SUITE 302

BRIDGEWATER, NJ, 08807